In a filing, Procept BioRobotics Corp revealed its EVP, CLO, CORP. SEC. Nouri Alaleh unloaded Company’s shares for reported $1.92 million on May 03 ’24. In the deal valued at $62.97 per share,30,432 shares were sold. As a result of this transaction, Nouri Alaleh now holds 62,472 shares worth roughly $4.02 million.
Then, Krummel Thomas M sold 20,000 shares, generating $1,200,000 in total proceeds. Upon selling the shares at $60.00, the Director now owns 45,631 shares.
Before that, Zadno Reza sold 5,391 shares. Procept BioRobotics Corp shares valued at $263,243 were divested by the President, CEO at a price of $48.83 per share. As a result of the transaction, Zadno Reza now holds 241,319 shares, worth roughly $15.52 million.
Piper Sandler initiated its Procept BioRobotics Corp [PRCT] rating to an Overweight in a research note published on August 11, 2023; the price target was $42. A number of analysts have revised their coverage, including William Blair’s analysts, who began to cover the stock in late May with a ‘”an Outperform”‘ rating. BTIG Research began covering PRCT with “Neutral” recommendation on October 31, 2022. Truist started covering the stock on October 25, 2022. It rated PRCT as “a Buy”.
Price Performance Review of PRCT
On Friday, Procept BioRobotics Corp [NASDAQ:PRCT] saw its stock jump 4.16% to $64.31. Over the last five days, the stock has gained 24.08%. Procept BioRobotics Corp shares have risen nearly 53.45% since the year began. Nevertheless, the stocks have risen 120.84% over the past one year. While a 52-week high of $63.26 was reached on 05/03/24, a 52-week low of $24.83 was recorded on 01/05/24. SMA at 50 days reached $50.24, while 200 days put it at $40.26. A total of 1.14 million shares were traded, compared to the trading of 1.02 million shares in the previous session.
Levels Of Support And Resistance For PRCT Stock
The 24-hour chart illustrates a support level at 61.69, which if violated will result in even more drops to 59.07. On the upside, there is a resistance level at 65.91. A further resistance level may holdings at 67.51. The Relative Strength Index (RSI) on the 14-day chart is 78.41, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 8.06, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 3.54%. Stochastics %K at 89.40% indicates the stock is a selling.
The most recent change occurred on September 02, 2022 when Wells Fargo began covering the stock and recommended ‘”an Overweight”‘ rating along with a $49 price target.
